Hematopoietic Stem Cells for Transplantation
Hematopoietic Stem Cells for Transplantation
批准号:
7355791
负责人:
CURT I CIVIN
金额:
$203.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-26 至 2013-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This grant proposal focuses our sustained laboratory and clinical research experience in animal and human stem cell biology and leukemia to extend exciting new investigations on normal tissue-specific and cancer stem cells. The investigators in this PPG look forward to discovering key information about the defining characteristics of cancer stem cells. This knowledge will enable us to develop new methods to better identify and isolate these rare cells for further study. In addition, this PPG seeks increased understanding of the pathophysiologic mechanisms of cancer stem cells, particularly the signaling pathways that these cells depend on for their persistence and other malignant behavior. This basic information will suggest new clinical cancer stem cell targets, which we will proceed to attack via pharmacologic and biologic approaches. Both within the Projects and in interactions among the Projects and Cores, clinical research and laboratory inquiries will proceed in parallel, so that insights generated in one sphere will translate to, and promote progress in the other. We believe that our highly interactive, closely integrated, translational approach is the best way to determine mechanisms of normal and malignant stem cell biology, and simultaneously to develop new treatments utilizing normal stem cells and targeting malignant stem cells in human diseases.
Relevance: There is growing evidence suggesting that many cancers originate in early (stem or progenitor) cells and that the mature cancers continue to be maintained by a stem-progenitor cell hierarchy. Our group has provided important evidence demonstrating the existence of discrete populations of cancer stem cells in human diseases, and our results support the prediction that cancer recurrence in patients after chemotherapy may be due to failure to eradicate the rare, sustaining cancer stem cell population, despite massive reduction of the predominant bulk population of mature cancer cells. The investigators in this PPG look forward to discovering key information about the defining characteristics and molecular mechanisms of cancer stem cells that will provide new ways to identify and attack cancer stem cells therapeutically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthetic Strategies to Restore the Efficacy of Venetoclax in Acute Myeloid Leukemia
-
批准号:10290284
-
项目类别:
-
资助金额:$21.67万
-
财政年份:2021
-
负责人:CURT I CIVIN
-
依托单位:
Synthetic Strategies to Restore the Efficacy of Venetoclax in Acute Myeloid Leukemia
-
批准号:10457407
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2021
-
负责人:CURT I CIVIN
-
依托单位:
Microfluidic CAR-T Cell Processing Device
-
批准号:9929262
-
项目类别:
-
资助金额:$92.44万
-
财政年份:2018
-
负责人:CURT I CIVIN
-
依托单位:
High Efficiency Microfluidic Purification of Stem Cells to Improve Transplants
-
批准号:8313288
-
项目类别:
-
资助金额:$24.13万
-
财政年份:2012
-
负责人:CURT I CIVIN
-
依托单位:
Microfluidic Processing of Leukocytes for Molecular Diagnostic Testing
-
批准号:8455782
-
项目类别:
-
资助金额:$24.5万
-
财政年份:2012
-
负责人:CURT I CIVIN
-
依托单位:
MICRO RNA TARGETING OF NORMAL & LEUKEMIA STEM- PROGENITOR CELLS
-
批准号:8212935
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2011
-
负责人:CURT I CIVIN
-
依托单位:
Research Administration
-
批准号:8212939
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2011
-
负责人:CURT I CIVIN
-
依托单位:
MicroRNAs regulating erythroid development
-
批准号:8010060
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:CURT I CIVIN
-
依托单位:
MicroRNAs regulating erythroid development
-
批准号:7982725
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2008
-
负责人:CURT I CIVIN
-
依托单位:
MicroRNAs regulating erythroid development
-
批准号:7862406
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2008
-
负责人:CURT I CIVIN
-
依托单位:
MICRO RNA TARGETING OF NORMAL & LEUKEMIA STEM- PROGENITOR CELLS
-
批准号:7355829
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2007
-
负责人:CURT I CIVIN
-
依托单位:
Research Administration
-
批准号:7355831
-
项目类别:
-
资助金额:$10.48万
-
财政年份:2007
-
负责人:CURT I CIVIN
-
依托单位:
Fas ligand+ blood cells to reduce transplant rejection
-
批准号:6783390
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2002
-
负责人:CURT I CIVIN
-
依托单位:
Fas ligand+ blood cells to reduce transplant rejection
-
批准号:6663208
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2002
-
负责人:CURT I CIVIN
-
依托单位:
Fas ligand+ cells to reduce transplant rejection
-
批准号:6744281
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2002
-
负责人:CURT I CIVIN
-
依托单位:
Fas ligand+ blood cells to reduce transplant rejection
-
批准号:6570677
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2002
-
负责人:CURT I CIVIN
-
依托单位:
Fas/FasL mediated apoptosis in GVHD and aplastic anemia
-
批准号:6667400
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2002
-
负责人:CURT I CIVIN
-
依托单位:
HUMAN-MOUSE CHIMERA ASSAYS
-
批准号:6579392
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2001
-
负责人:CURT I CIVIN
-
依托单位:
HUMAN-MOUSE CHIMERA ASSAYS
-
批准号:6456221
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2001
-
负责人:CURT I CIVIN
-
依托单位:
CORE--BIOSTATISTICS AND FACS
-
批准号:6456224
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2001
-
负责人:CURT I CIVIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
BCL3介导前列腺癌Lum stem-like细胞干性维持与内分泌治疗抵抗的机制研究
-
批准号:2026JJ70013
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:汤谷雨
-
依托单位:
过渡金属氧化物电催化CO2性能的原位4D-STEM研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李梦莎
-
依托单位:
基于图谱补全与评价循证的中学STEM课程资源智能组织方法研究
-
批准号:62307023
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:林健
-
依托单位:
科学传播类:跨学科STEM科普活动实践与科技创新人才培养机制研究
-
批准号:T2241013
-
项目类别:专项项目
-
资助金额:10.00万元
-
批准年份:2022
-
负责人:江丰光
-
依托单位:
利用iDPC-STEM与冷冻电子断层成像技术相结合的方式解析生物厚样品原位高分辨三维结构
-
批准号:32241024
-
项目类别:专项项目
-
资助金额:100.00万元
-
批准年份:2022
-
负责人:黄小俊
-
依托单位:
调控胰岛特异性stem-like CD8+ Tm细胞能量代谢免疫治疗1型糖尿病研究
-
批准号:82230028
-
项目类别:重点项目
-
资助金额:261万元
-
批准年份:2022
-
负责人:杨涛
-
依托单位:
STEM教育情境下多人同伴互动的脑协同机制与策略研究
-
批准号:62177011
-
项目类别:面上项目
-
资助金额:47万元
-
批准年份:2021
-
负责人:董艳
-
依托单位:
线粒体tRNA ACC-stem突变在母系遗传性高血压发病中的功能及机制研究
-
批准号:82070434
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2020
-
负责人:刘昱圻
-
依托单位:
基于STEM的异质结构变形测试方法与晶格结构重构技术研究
-
批准号:12002116
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:温辉辉
-
依托单位:
STEM三维云纹法及在单晶高温合金损伤行为研究中的应用
-
批准号:11972084
-
项目类别:面上项目
-
资助金额:68.0万元
-
批准年份:2019
-
负责人:刘战伟
-
依托单位: